Patents expiring in 2033

US 2013210912

Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same

BAUSCH & LOMB [US] · Granted Thu Aug 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2012210489

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

4SC DISCOVERY GMBH [DE] · Granted Thu Aug 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2012210491

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

4SC DISCOVERY GMBH [DE] · Granted Thu Aug 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2864029

NOUVELLES UTILISATIONS PEDIATRIQUES DU CABAZITAXEL

AVENTIS PHARMA SA [FR] · Granted Thu Aug 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512755

Compact multifunctional ligand to enhance colloidal stability of nanoparticles

United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512751

Pharmaceutical compositions for sleep disorders

Collegium Pharmaceutical, Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513209

Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

The Board of Regents of the University of Texas System · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513282

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513432

Dual-acting benzoimidazole antihypertensive agents

Theravance, Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513252

Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513198

Pharmaceutical formulation for reducing pain

Jazz Pharmaceuticals International III Limited · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512964

Targets for treatment of hypercholesterolemia

The Regents of the University of California · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512258

Breath test device and method

EXALENZ BIOSCIENCE LTD. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512693

Self-assembling membranes and related methods thereof

Northwestern University · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512712

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512746

Extended release pharmaceutical compositions of levetiracetam

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513005

DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513197

Ganglioside epitopes for treating Guillain-Barre syndrome

Georgia Regents University · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513214

C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513230

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513244

Neprilysin inhibitors

Theravance, Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513251

Pyridazinone compounds

Takeda Pharmaceutical Company Limited · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513302

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

The Regents of the University of California · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513390

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513414

Processes and intermediates for producing azaindoles

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8513489

Uses of antimicrobial genes from microbial genome

The Regents of the University of California · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518938

c-MET protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518968

Hydrazone and diacyl hydrazine compounds and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518871

Skin permeating and cell entering (SPACE) peptides and methods of use thereof

The Regents of the University of California · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518404

Activatable binding polypeptides and methods of identification and use thereof

The Regents of the University of California · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518636

Tangential flow filtration devices and methods for leukocyte enrichment

Northwest Biotherapeutics, Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518440

Biodegradable osmotic pump implant for drug delivery

Covidien LP · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518887

Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518890

Remedies for sex hormone dependent disease

Takeda Pharmaceutical Company Limited · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518390

Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8519002

Colchicine solid complex; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518647

Method of diagnosing poor survival prognosis colon cancer using miR-16b

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518870

Compositions and methods for cancer treatment using targeted carbon nanotubes

The Board of Regents of the University of Oklahoma · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518884

Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor

Northwestern University · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518937

Pyrimidinediamine kinase inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518953

Aminopyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518980

Treatment of Duchenne muscular dystrophy

Summit Corporation Plc · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8519137

Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8518984

Spiro-oxindole MDM2 antagonists

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8519103

Factor VII polypeptides that are modified and uses thereof

Catalyst Biosciences, Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8519158

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)